In this issue:
Cotransplantation of autologous Tregs in cell therapy for PD
Botulinum toxin for treating motor dysfunction in PD
Venglustat for GBA1-associated PD
Cholinesterase inhibitors for psychotic symptoms in PD and Alzheimer’s
PD risk after trichloroethylene exposure
Connectivity profile for STN-DBS in early PD
Association of physical activity and PD in women
PD risk increased in patients with AMD and visual disability
Please login below to download this issue (PDF)